Targeted disruption of the chemokine receptor CCR1 in bone marrow cells enhances atherosclerotic lesion development and inflammation in LDL receptor-deficient mice

被引：0
|
作者：
Potteaux, S
Combadiere, C
Esposito, B
Casanova, S
Merval, R
Ardouin, P
Gao, JL
Murphy, PM
Tedgui, A
Mallat, Z
机构：
[1] INSERM, U541, Paris, France
[2] INSERM, U543, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] NIAID, Bethesda, MD 20892 USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1494
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [31] Deletion of angiotensin II type I receptor in bone marrow reduced atherosclerotic lesion formation in ApoE deficient mice
    Fukuda, Daiju
    Sata, Masataka
    Nagai, Ryozo
    CIRCULATION, 2006, 114 (18) : 185 - 185
  • [32] ApoE-Dependent Modulation of HDL and Atherosclerosis by G2A in LDL Receptor-Deficient Mice Independent of Bone Marrow-Derived Cells
    Parks, Brian W.
    Srivastava, Roshni
    Yu, Shaohua
    Kabarowski, Janusz H. S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (04) : 539 - U225
  • [33] CD44 on bone marrow-derived cells limits T-Cell recruitment but is not required for atherogenesis in LDL receptor-deficient mice
    Sjöberg, Sara
    Carlsson, Annelie
    Skälén, Kristina
    Levin, Max
    Borén, Jan
    Krettek, Alexandra
    CIRCULATION, 2006, 114 (18) : 286 - 287
  • [34] Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
    Febbraio, M
    Podrez, EA
    Smith, JD
    Hajjar, DP
    Hazen, SL
    Hoff, HF
    Sharma, K
    Silverstein, RL
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08): : 1049 - 1056
  • [35] Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice
    Pennings, Marieke
    Hildebrand, Reeni B.
    Ye, Dan
    Kunne, Cindy
    Van Berkel, Theo J. C.
    Groen, Albert K.
    Van Eck, Miranda
    CARDIOVASCULAR RESEARCH, 2007, 76 (01) : 175 - 183
  • [36] BONE MARROW DEFICIENCY IN MELANOCORTIN-1 RECEPTOR ENHANCES LEUKOCYTOSIS IN APOE-/- ATHEROSCLEROTIC MICE
    Kadiri, J.
    Tadayon, S.
    Hollmen, M.
    Rinne, P.
    ATHEROSCLEROSIS, 2020, 315 : E23 - E23
  • [37] Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice
    Enkhmaa, B
    Shiwaku, K
    Katsube, T
    Kitajima, K
    Anuurad, E
    Yamasaki, M
    Yamane, Y
    JOURNAL OF NUTRITION, 2005, 135 (04): : 729 - 734
  • [38] Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells
    Zhuge, Xin
    Arai, Hidenori
    Xu, Yang
    Murayama, Toshinorl
    Kobayashi, Takuya
    Narumiya, Shuh
    Kita, Toru
    Yokode, Masayuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (04) : 865 - 871
  • [39] Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice
    Van Eck, Miranda
    Ye, Dan
    Hildebrand, Reeni B.
    Kruijt, J. Kar
    de Haan, Willeke
    Hoekstra, Menno
    Rensen, Patrick C. N.
    Ehnholm, Christian
    Jauhiainen, Matti
    Van Berkel, Theo J. C.
    CIRCULATION RESEARCH, 2007, 100 (05) : 678 - 685
  • [40] Macrophage expression of Group IIA sPLA2 in LDL receptor-deficient mice increases atherosclerotic lesion formation in the absence of systemic effects on lipoprotein metabolism
    Bostrom, MA
    De Beer, FC
    Daugherty, A
    Webb, NR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A69 - A69
12345